type 2 diabetes mellitus diabetes mellitus
Conditions
Interventions
After written informed consents are obtained, 60 participants would be classified randomly into 2 groups
one in which participants would be equipped with FreeStyle Libre sensors during the first 12 weeks and the other in which participants would not be equipped with FreeStyle Libre2. We measure HbA1c at
Sponsors
Arima Hiroshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diabetes patients who 1)are diagnosed type 2 diabetes mellitus 2)have HbA1c level of 7.0% or more and less than 8.0% 3)are 20 years of age or older 4) are not prescribed any hypoglycemic drug
Exclusion criteria
Exclusion criteria: Those who have hyperglycaemic symptoms or ketosis Those whose anti-GAD Abs are positive Those who have been using self-monitaring of blood glucose THose who have preproliferative or proliferative diabetic retinopathy Those who have severe renal failure (eGFR<30/ml/min/1.73m3) Those who are judged by their physicians to be unsuitable for enrolling the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug-free period | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c, fasting blood glucose body weight, BMI blood pressure total-C, HDL-C, LDL-C, TG drugs DTSQ (Diabetes Treatment Satisfaction Questionnaire) IPAQ (International Physical Activity Questionnaire) BDHQ (brief-type self-administered diet history questionnaire) adverse events FGM data | — |
Contacts
Public ContactTomoko Kobayashi
Nagoya University Hospital
Outcome results
None listed